These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9707351)

  • 41. Pharmacokinetics of thiamylal enantiomers in humans.
    Sueyasu M; Ikeda T; Taniyama T; Futugami K; Kataoka Y; Oishi R
    Int J Clin Pharmacol Ther; 1997 Mar; 35(3):128-32. PubMed ID: 9089003
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Steady-state concentration of venlafaxine enantiomers: model-based analysis of between-patient variability.
    Gex-Fabry M; Rudaz S; Balant-Gorgia AE; Brachet A; Veuthey JL; Balant LP; Bertschy G
    Eur J Clin Pharmacol; 2002 Aug; 58(5):323-31. PubMed ID: 12185556
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tolerability and pharmacokinetics of metformin and the dipeptidyl peptidase-4 inhibitor sitagliptin when co-administered in patients with type 2 diabetes.
    Herman GA; Bergman A; Yi B; Kipnes M;
    Curr Med Res Opin; 2006 Oct; 22(10):1939-47. PubMed ID: 17022853
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics of beclobric acid enantiomers and their conjugates after single and multiple oral dosage of racemic beclobrate.
    Mayer S; Spahn-Langguth H; Gikalov I; Mutschler E
    Arzneimittelforschung; 1993 Jan; 43(1):40-3. PubMed ID: 8447845
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multiple-dose pharmacokinetics of intravenous telavancin in healthy male and female subjects.
    Wong SL; Barriere SL; Kitt MM; Goldberg MR
    J Antimicrob Chemother; 2008 Oct; 62(4):780-3. PubMed ID: 18586659
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stereoselective pharmacokinetics of disopyramide enantiomers in man.
    Lima JJ; Boudoulas H; Shields BJ
    Drug Metab Dispos; 1985; 13(5):572-7. PubMed ID: 2865105
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stereoselective pharmacokinetics of methadone in beagle dogs.
    Schmidt N; Brune K; Williams KM; Geisslinger G
    Chirality; 1994; 6(6):492-5. PubMed ID: 7946975
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stereoselective pharmacokinetics of diniconazole enantiomers in rabbits.
    Wang Q; Qiu J; Zhou Z; Cao A; Wang X; Zhu W; Dang Z
    Chirality; 2009 Jul; 21(7):699-703. PubMed ID: 18973222
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stereoselective metabolism and pharmacokinetics of racemic methylphenobarbital in humans.
    Lim WH; Hooper WD
    Drug Metab Dispos; 1989; 17(2):212-7. PubMed ID: 2565213
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Direct enantioselective determination of (R)- and (S)-propranolol in human plasma. Application to pharmacokinetic studies.
    Egginger G; Lindner W; Brunner G; Stoschitzky K
    J Pharm Biomed Anal; 1994 Dec; 12(12):1537-45. PubMed ID: 7696378
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetic study of a new sustained release preparation of propranolol in normal healthy volunteers.
    Biswas NR; Garg SK; Lal R; Kumar N; Gyawali K; Narendranath KA; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1988 Sep; 26(9):436-8. PubMed ID: 3198297
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of endotoxin on the stereoselective pharmacokinetics of oxprenolol, propranolol, and verapamil in the rat.
    Laethem ME; Belpaire FM; Wijnant P; Rosseel MT; Bogaert MG
    Chirality; 1994; 6(5):405-10. PubMed ID: 8068500
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stereoselective high-performance liquid chromatography determination of propranolol and 4-hydroxypropranolol in human plasma after pre-column derivatization.
    Wu ST; Chang YP; Gee WL; Benet LZ; Lin ET
    J Chromatogr B Biomed Sci Appl; 1997 Apr; 692(1):133-40. PubMed ID: 9187392
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stereospecific assay for (-)- and (+)-propranolol in human and dog plasma.
    Silber B; Riegelman S
    J Pharmacol Exp Ther; 1980 Dec; 215(3):643-8. PubMed ID: 7441523
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stereoselective differences in propranolol disposition in female Sprague-Dawley and Dark Agouti rats.
    Guttendorf RJ; Kostenbauder HB; Wedlund PJ
    Drug Metab Dispos; 1991; 19(1):251-6. PubMed ID: 1673410
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics and metabolism of the pharmacologically active 4'-hydroxylated metabolite of propranolol in the dog.
    Christ DD; Walle UK; Oatis JE; Walle T
    Drug Metab Dispos; 1990; 18(1):1-4. PubMed ID: 1970766
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of severity of inflammation on the disposition kinetics of propranolol enantiomers in ketoprofen-treated and untreated adjuvant arthritis.
    Piquette-Miller M; Jamali F
    Drug Metab Dispos; 1995 Feb; 23(2):240-5. PubMed ID: 7736918
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma protein binding of ketoprofen enantiomers in man: method development and its application.
    Hayball PJ; Nation RL; Bochner F; Newton JL; Massy-Westropp RA; Hamon DP
    Chirality; 1991; 3(6):460-6. PubMed ID: 1812956
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modification of propranolol's bioavailability by Eurycoma longifolia water-based extract.
    Salman SA; Amrah S; Wahab MS; Ismail Z; Ismail R; Yuen KH; Gan SH
    J Clin Pharm Ther; 2010 Dec; 35(6):691-6. PubMed ID: 21054461
    [TBL] [Abstract][Full Text] [Related]  

  • 60. N-dealkylation of propranolol in rat, dog, and man. Chemical and stereochemical aspects.
    Nelson WL; Bartels MJ
    Drug Metab Dispos; 1984; 12(3):345-52. PubMed ID: 6145562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.